Medicare Enrolled
Dr. Ruben Almanza, MD
Family Medicine · Corpus Christi, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Almanza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Almanza?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Almanza
Dr. Ruben Almanza is a family medicine specialist in Corpus Christi, TX, with 21 years of NPI registration. Based on federal Medicare data, Dr. Almanza performed 1,178 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Almanza received a total of $15,395 from 51 pharmaceutical and/or device companies across 790 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Almanza is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 21 years of NPI registration
▲ Top 24% volume in TX
$15,395 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗1,178
Medicare services
Top 24% in TX for family medicine
Not available
Unique patients (not deduplicated)
$67
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
306 | $52 | $182 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
251 | $83 | $266 |
| Annual wellness visit, follow-up A follow-up annual wellness visit that includes a personalized prevention plan of service. |
122 | $123 | $282 |
| Annual depression screening | 89 | $17 | $50 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
57 | $30 | $48 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
53 | $126 | $357 |
| Quadrivalent influenza vaccine, preservative-free A flu shot containing four strains of the influenza virus, formulated without preservatives, administered in a 0.5 ml dose. |
43 | $22 | $60 |
| Pneumococcal conjugate vaccine (PCV20) An intramuscular injection of the 20-valent pneumococcal conjugate vaccine. It is used to protect against diseases caused by Streptococcus pneumoniae bacteria. |
37 | $283 | $850 |
| Pneumonia vaccine administration This procedure involves the injection of a vaccine to protect against pneumococcal disease. It is administered by a healthcare provider. |
36 | $30 | $44 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
30 | $15 | $55 |
| SARS-CoV-2 immunoassay test A laboratory test using immunoassay techniques to detect the presence of severe acute respiratory syndrome coronavirus. |
26 | $33 | $144 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
25 | $9 | $41 |
| Influenza virus nucleic acid detection test A laboratory test that uses nucleic acid technology to detect multiple types of influenza virus. |
20 | $94 | $135 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
18 | $10 | $41 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
18 | $41 | $110 |
| Smoking cessation counseling, more than 10 minutes Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes. |
17 | $26 | $70 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
15 | $4 | $31 |
| Influenza vaccine, quadrivalent, 0.5 ml dosage | 15 | $20 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$15,395
Total received (2018-2024)
Avg $2,199/year across 7 years
Top 2% in TX for family medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
790
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,237
2023
$1,676
2022
$1,683
2021
$2,229
2020
$2,012
2019
$3,122
2018
$2,436
Payments by company (2024)
Lilly USA, LLC
$382
Novo Nordisk Inc
$344
Amgen Inc.
$268
Bayer Healthcare Pharmaceuticals Inc.
$255
AstraZeneca Pharmaceuticals LP
$204
PFIZER INC.
$190
GlaxoSmithKline, LLC.
$163
Otsuka America Pharmaceutical, Inc.
$125
Boehringer Ingelheim Pharmaceuticals, Inc.
$91
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$43
SHIELD THERAPEUTICS INC
$27
Sumitomo Pharma America, Inc.
$26
Phathom Pharmaceuticals, Inc.
$22
Exact Sciences Corporation
$22
Novartis Pharmaceuticals Corporation
$22
Esperion Therapeutics, Inc.
$18
Dexcom, Inc.
$17
ABBVIE INC.
$17
Top 3 companies account for 44.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,149
Lilly USA, LLC
$2,065
Novo Nordisk Inc
$1,972
Amgen Inc.
$1,875
SANOFI-AVENTIS U.S. LLC
$711
Amarin Pharma Inc.
$602
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$550
PFIZER INC.
$543
Janssen Pharmaceuticals, Inc
$397
GlaxoSmithKline, LLC.
$391
Teva Pharmaceuticals USA, Inc.
$370
Boehringer Ingelheim Pharmaceuticals, Inc.
$344
Bayer Healthcare Pharmaceuticals Inc.
$303
Nevro Corp.
$289
Allergan, Inc.
$275
Allergan Inc.
$240
Shire North American Group Inc
$224
Novartis Pharmaceuticals Corporation
$217
AbbVie Inc.
$196
Biohaven Pharmaceutical Holding Company Ltd.
$195
Eisai Inc.
$161
Merck Sharp & Dohme Corporation
$160
Biohaven Pharmaceuticals, Inc.
$130
Esperion Therapeutics, Inc.
$127
Otsuka America Pharmaceutical, Inc.
$125
Paratek Pharmaceuticals, Inc.
$68
Genentech USA, Inc.
$57
Astellas Pharma US Inc
$54
Upsher-Smith Laboratories LLC
$53
Exact Sciences Corporation
$49
UPSHER-SMITH LABORATORIES LLC
$46
Abbott Laboratories
$38
Bayer HealthCare Pharmaceuticals Inc.
$32
Merck Sharp & Dohme LLC
$31
OPTOS, INC.
$30
ABBVIE INC.
$30
Medtronic, Inc.
$29
ARBOR PHARMACEUTICALS, INC.
$27
SHIELD THERAPEUTICS INC
$27
Sumitomo Pharma America, Inc.
$26
Takeda Pharmaceuticals U.S.A., Inc.
$24
Alcon Laboratories Inc
$23
Phathom Pharmaceuticals, Inc.
$22
Boston Scientific Corporation
$18
Dexcom, Inc.
$17
EISAI INC.
$16
Melinta Therapeutics, Inc.
$16
Lundbeck LLC
$15
Hikma Pharmaceuticals USA
$13
Kowa Pharmaceuticals America, Inc.
$12
DEXCOM, INC.
$11
Top 3 companies account for 40.2% of all-time payments
Associated products mentioned in payments ›
ACCRUFER · ADVAIR · AIRSUPRA · AJOVY · AREXVY · Aimovig · BASAGLAR · BELSOMRA · BREZTRI · BYSTOLIC · Baxdela · Belviq · CHANTIX · COMIRNATY · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EUCRISA · Edarbi · FARXIGA · FREESTYLE LIBRE 2 · FreeStyle Libre 2 · GEMTESA · GENERAL PAIN MANAGEMENT · INVOKANA · JANUVIA · JARDIANCE · Kerendia · LEQVIO · LINZESS · LYRICA · MOUNJARO · MYDAYIS · Mitigare · Monaco · Myrbetriq · NEXLETOL · NURTEC ODT · NUVENT · NUZYRA · OFEV · Omnia · Otezla · Ozempic · PAXLOVID · PREVNAR 13 · PREVNAR 20 · QULIPTA · REXULTI · RYBELSUS · ReSTOR · Repatha · Rybelsus · SHINGRIX · SIVEXTRO · SOLIQUA · SOLIQUA 100/33 · STEGLATRO · SYMBICORT · Saxenda · Seglentis · Senza · TOSYMRA · TOSYMRA SUMATRIPTAN NASAL SPRAY · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULANCE · TRULICITY · UBRELVY · VOQUEZNA · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · Xofluza
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Family medicine physicians in nearby ZIP areas
194
County median income
$66,021
Nearest hospital to ZIP centroid (approximate)
CORPUS CHRISTI MEDICAL CENTER,THE
3.4 mi
3.4 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Almanza is a clinical cardiology specialist, with above-average Medicare volume (top 24% in TX), with 21 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Almanza experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Almanza performed 306 office visit, established patient (20-29 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Almanza receive payments from pharmaceutical companies?
Yes. Dr. Almanza received a total of $15,395 from 51 companies across 790 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Almanza's costs compare to other family medicine physicians in Corpus Christi?
Dr. Almanza's average Medicare payment per service is $67. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Almanza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicine Physicians in Corpus Christi
Browse family medicine physicians in Corpus Christi ranked by procedure volume and transparency data.
Highest volume
Top Family Medicine Physicians in TX
Family medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicine Physicians in TX
Which TX family medicine physicians receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
Lilly USA, LLC Payments to Doctors
See all physicians who received payments from Lilly USA, LLC.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology